ArticleFrontiers in oncology2025
Single center experience of the impact of artificial intelligence image analysis software on short-term prognosis of non-small cell lung cancer.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the single center experience of the value of artificial intelligence image analysis software in short-term prognostic assessment of non-small cell lung cancer. Methods: Artificial intelligence image analysis software was used to analyze typical cases of NSCLC in our hospital; 450 patients diagnosed with NSCLC were selected as research subjects, Single-factor and multi-factor COX proportional hazards regression were used to analyze the imaging features that affect the short-term survival prognosis (progression/death within 12 months) of NSCLC patients, and the short-term prognostic predictive value of each independent predictor factor was analyzed through the receiver operating characteristic (ROC) curve. Results: The artificial intelligence image analysis software can accurately identify and segment tumor areas, extract key features such as tumor size, shape, and texture, and help doctors diagnose and treat patients more efficiently and accurately. COX regression analysis showed that the maximum diameter of the tumor, spiculation sign, vascular bundle sign, pleural indentation sign, calcification and lymph node metastasis are all imaging features that affect the prognosis of NSCLC patients. The ROC curve shows that the areas under the curve (AUC) of the six factors are 0.676, 0.768, 0.689, 0.696, 0.713, 0.810, respectively, with 95% confidence intervals (95%CI) are =0.576~0.740, 0.663~0.847, 0.610~0.763, 0.590~0.781, 0.614~0.808, 0.716~0.886 respectively. The precision-recall curve of lymph node metastasis and spiculation sign performed best. Even under high recall rate, the precision rate remained above 0.7. The model quality score showed that lymph node metastasis had the highest score (0.74) and spiculation sign was 0.66. Conclusion: The imaging analysis software based on artificial intelligence can significantly improve the accuracy of assessment of NSCLC patients, help improve the short-term prognosis of patients, and has short-term clinical application value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.